Jonathan Wolleben
Stock Analyst at JMP Securities
(4.14)
# 552
Out of 4,479 analysts
142
Total ratings
45.7%
Success rate
14.68%
Average return
Main Sectors:
Top Industries:
20 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals | Maintains: Market Outperform | $66 → $68 | $33.68 | +101.90% | 8 | Jun 18, 2024 | |
| PTGX Protagonist Therapeutics | Reiterates: Market Outperform | $45 | $34.59 | +30.10% | 8 | Jun 17, 2024 | |
| SGMT Sagimet Biosciences | Reiterates: Market Outperform | $48 | $2.93 | +1,538.23% | 7 | Jun 7, 2024 | |
| CRNX Crinetics Pharmaceuticals | Reiterates: Market Outperform | $80 | $45.54 | +75.67% | 11 | Jun 4, 2024 | |
| LRMR Larimar Therapeutics | Reiterates: Market Outperform | $25 | $7.71 | +224.25% | 11 | May 31, 2024 | |
| GPCR Structure Therapeutics | Reiterates: Market Outperform | $91 | $38.73 | +134.96% | 5 | May 10, 2024 | |
| ALT Altimmune | Maintains: Market Outperform | $25 → $24 | $6.74 | +256.08% | 9 | May 10, 2024 | |
| OCUL Ocular Therapeutix | Maintains: Market Outperform | $24 → $22 | $6.68 | +229.34% | 14 | May 8, 2024 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Market Outperform | $397 → $381 | $271.67 | +40.24% | 8 | May 8, 2024 | |
| BCRX BioCryst Pharmaceuticals | Maintains: Market Outperform | $14 → $15 | $6.55 | +129.01% | 2 | May 7, 2024 | |
| SVRA Savara | Reiterates: Market Outperform | $8 | $4.30 | +86.05% | 4 | May 6, 2024 | |
| RLYB Rallybio | Reiterates: Market Outperform | $8 | $1.20 | +566.67% | 11 | Apr 19, 2024 | |
| PHVS Pharvaris | Maintains: Market Outperform | $49 → $50 | $16.85 | +196.74% | 9 | Apr 11, 2024 | |
| SPRB Spruce Biosciences | Maintains: Market Outperform | $8 → $3 | $0.53 | +468.94% | 6 | Mar 14, 2024 | |
| CLSD Clearside Biomedical | Reiterates: Market Outperform | $5 | $1.23 | +306.50% | 8 | Mar 13, 2024 | |
| ALLK Allakos | Maintains: Market Outperform | $10 → $3 | $0.84 | +256.89% | 4 | Jan 17, 2024 | |
| AURA Aura Biosciences | Maintains: Market Outperform | $21 → $19 | $7.15 | +165.73% | 4 | Nov 10, 2023 | |
| DBVT DBV Technologies | Reiterates: Market Outperform | $8 | $0.77 | +936.40% | 8 | Aug 1, 2023 | |
| PRQR ProQR Therapeutics | Reiterates: Market Outperform | $6 | $1.65 | +264.74% | 4 | May 17, 2023 | |
| WMG Warner Music Group | Maintains: Outperform | $25 → $24 | $30.61 | -21.59% | 1 | May 12, 2023 |
Mirum Pharmaceuticals
Jun 18, 2024
Maintains: Market Outperform
Price Target: $66 → $68
Current: $33.68
Upside: +101.90%
Protagonist Therapeutics
Jun 17, 2024
Reiterates: Market Outperform
Price Target: $45
Current: $34.59
Upside: +30.10%
Sagimet Biosciences
Jun 7, 2024
Reiterates: Market Outperform
Price Target: $48
Current: $2.93
Upside: +1,538.23%
Crinetics Pharmaceuticals
Jun 4, 2024
Reiterates: Market Outperform
Price Target: $80
Current: $45.54
Upside: +75.67%
Larimar Therapeutics
May 31, 2024
Reiterates: Market Outperform
Price Target: $25
Current: $7.71
Upside: +224.25%
Structure Therapeutics
May 10, 2024
Reiterates: Market Outperform
Price Target: $91
Current: $38.73
Upside: +134.96%
Altimmune
May 10, 2024
Maintains: Market Outperform
Price Target: $25 → $24
Current: $6.74
Upside: +256.08%
Ocular Therapeutix
May 8, 2024
Maintains: Market Outperform
Price Target: $24 → $22
Current: $6.68
Upside: +229.34%
Madrigal Pharmaceuticals
May 8, 2024
Maintains: Market Outperform
Price Target: $397 → $381
Current: $271.67
Upside: +40.24%
BioCryst Pharmaceuticals
May 7, 2024
Maintains: Market Outperform
Price Target: $14 → $15
Current: $6.55
Upside: +129.01%
Savara
May 6, 2024
Reiterates: Market Outperform
Price Target: $8
Current: $4.30
Upside: +86.05%
Rallybio
Apr 19, 2024
Reiterates: Market Outperform
Price Target: $8
Current: $1.20
Upside: +566.67%
Pharvaris
Apr 11, 2024
Maintains: Market Outperform
Price Target: $49 → $50
Current: $16.85
Upside: +196.74%
Spruce Biosciences
Mar 14, 2024
Maintains: Market Outperform
Price Target: $8 → $3
Current: $0.53
Upside: +468.94%
Clearside Biomedical
Mar 13, 2024
Reiterates: Market Outperform
Price Target: $5
Current: $1.23
Upside: +306.50%
Allakos
Jan 17, 2024
Maintains: Market Outperform
Price Target: $10 → $3
Current: $0.84
Upside: +256.89%
Aura Biosciences
Nov 10, 2023
Maintains: Market Outperform
Price Target: $21 → $19
Current: $7.15
Upside: +165.73%
DBV Technologies
Aug 1, 2023
Reiterates: Market Outperform
Price Target: $8
Current: $0.77
Upside: +936.40%
ProQR Therapeutics
May 17, 2023
Reiterates: Market Outperform
Price Target: $6
Current: $1.65
Upside: +264.74%
Warner Music Group
May 12, 2023
Maintains: Outperform
Price Target: $25 → $24
Current: $30.61
Upside: -21.59%